Pharmaceutical firm Gilead has admitted paying hundreds of thousands of dollars in illegal kickbacks to US doctors between ...

Gilead Sciences has agreed to pay USD 202 million to settle a whistleblower lawsuit that accused the company of engaging in ...

Gilead Sciences has agreed to pay $202 million to resolve allegations that it violated the Anti-Kickback Statute by using speaker programs to incentivize physicians to prescribe HIV medications.

Gilead will pay $202 million to resolve claims that it paid kickbacks to healthcare providers in the form of honoraria, meals ...

Dozens of trials on HIV ground to a halt in February after US President Donald Trump abruptly pulled crucial funding.

Here are 10 recent healthcare industry lawsuits, settlements and legal developments that Becker's has reported since April 22: ...

Altesa BioSciences, Inc., a clinical-stage pharmaceutical company developing new treatments for viral infections in vulnerable populations, today announced the appointment of Katharine Knobil, M.D. as ...

Ohio Wesleyan University has raised a record-breaking $50 million in just three months to fund a visionary, fine arts-infused ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

In April, the wild swings in policy positions from the White House resulted in similarly wild swings for the stock market. On one hand, investors hate uncertainty and the continually moving targets ...

Only 6.9% of people with drug-resistant infections in eight large, low- and middle-income countries received an appropriate ...

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment. The company ...